Learn About Non-Alcoholic Fatty Liver Disease

What is the definition of Non-Alcoholic Fatty Liver Disease?

Non-alcoholic fatty liver disease (NAFLD) is a buildup of excessive fat in the liver that can lead to liver damage resembling the damage caused by alcohol abuse, but that occurs in people who do not drink heavily. The liver is a part of the digestive system that helps break down food, store energy, and remove waste products, including toxins. The liver normally contains some fat; an individual is considered to have a fatty liver (hepatic steatosis) if the liver contains more than 5 to 10 percent fat.

Save information for later
Sign Up
What are the causes of Non-Alcoholic Fatty Liver Disease?

The specific causes of NAFLD are unclear. Genetic variations and environmental factors contribute to the development of this complex disorder.

How prevalent is Non-Alcoholic Fatty Liver Disease?

NAFLD is a very common disorder, occurring in about 25 percent of the global population. Its prevalence is increasing along with the rising prevalence of obesity in industrialized societies, and it is now the most common chronic liver disorder in Western countries, including the United States. NAFLD is more prevalent in individuals of Hispanic, Native American, or Asian ancestry than in individuals of European or African ancestry.

Is Non-Alcoholic Fatty Liver Disease an inherited disorder?

An increased risk of developing NAFLD can be passed through generations in families, but the inheritance pattern is unknown. Variations in several genes as well as lifestyle and environmental factors contribute to the risk of developing this complex disorder.

Who are the top Non-Alcoholic Fatty Liver Disease Local Doctors?
Elite
Highly rated in
10
conditions
Gastroenterology

Duke Health

Duke Endoscopy - Duke Clinic 2H

40 Duke Medicine Cir 
Durham, NC 27710

Manal Abdelmalek is a Gastroenterologist in Durham, North Carolina. Dr. Abdelmalek has been practicing medicine for over 30 years and is rated as an Elite doctor by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. She is also highly rated in 10 other conditions, according to our data. Her top areas of expertise are Nonalcoholic Steatohepatitis, Non-Alcoholic Fatty Liver Disease, Cirrhosis, and Alcoholic Cirrhosis. She is board certified in Gastroenterology and Internal Medicine and licensed to treat patients in North Carolina. Dr. Abdelmalek is currently accepting new patients.

Elite
Highly rated in
23
conditions
Gastroenterology

Northwestern Medicine

Northwestern Medicine Digestive Health Center

259 E Erie St 
Chicago, IL 60611

Mary Rinella is a Gastroenterologist in Chicago, Illinois. Dr. Rinella has been practicing medicine for over 26 years and is rated as an Elite doctor by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. She is also highly rated in 23 other conditions, according to our data. Her top areas of expertise are Non-Alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, Cirrhosis, and Hepatitis. She is board certified in Gastroenterology and Internal Medicine and licensed to treat patients in Illinois. Dr. Rinella is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn more
Elite
Highly rated in
11
conditions
Gastroenterology

University of California San Diego Health System

La Jolla 4510 Executive Dr

4510 Executive Dr 
San Diego, CA 92121

Rohit Loomba is a Gastroenterologist in San Diego, California. Dr. Loomba has been practicing medicine for over 23 years and is rated as an Elite doctor by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 11 other conditions, according to our data. His top areas of expertise are Non-Alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, Cirrhosis, and Alcoholic Cirrhosis. He is board certified in Gastroenterology and licensed to treat patients in California and Maryland. Dr. Loomba is currently accepting new patients.

What are the latest Non-Alcoholic Fatty Liver Disease Clinical Trials?
Quantitative Ultrasound Techniques for Diagnosis of Nonalcoholic Steatohepatitis
Match to trials
Find the right clinical trials for you in under a minute
Get started
Quantitative Ultrasound With Liver Incytes for Evaluation of Non-Alcoholic Fatty Liver Disease
Who are the sources who wrote this article ?

Published Date:updated Last, November

Published By: National Institutes of Health

What are the Latest Advances for Non-Alcoholic Fatty Liver Disease?
High Compliance to Mediterranean Diet Associates with Lower Platelet Activation and Liver Collagen Deposition in Patients with Nonalcoholic Fatty Liver Disease.
SGLT-2 Inhibitors in NAFLD: Expanding Their Role beyond Diabetes and Cardioprotection.
Tired of the same old research?
Check Latest Advances
Ezetimibe combination therapy with statin for non-alcoholic fatty liver disease: an open-label randomized controlled trial (ESSENTIAL study).